SCPS Scopus Biopharma Inc.

Scopus BioPharma Inc. develops therapeutics drugs targeting the endocannabinoid system. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December, 2017. The company was incorporated in 2017 and is based in New York, New York.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/30/2008
Outstanding shares:  18,094,264
Average volume:  40,568
Market cap:   $41,254,922
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    809171101
ISIN:        US8091711015
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   21.11
PS ratio:   0.00
Return on equity:   -1,072.25%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy